These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8423331)
1. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. Homeister JW; Satoh PS; Kilgore KS; Lucchesi BR J Immunol; 1993 Feb; 150(3):1055-64. PubMed ID: 8423331 [TBL] [Abstract][Full Text] [Related]
2. CD59 prevents human complement-mediated injuries in isolated guinea pig hearts. Wu S; Ma H; Huang S; Dong Y; Wu C; Shun J Chin Med J (Engl); 2002 Feb; 115(2):175-8. PubMed ID: 11940325 [TBL] [Abstract][Full Text] [Related]
3. Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart. Hong TT; White AJ; Lucchesi BR Int Immunopharmacol; 2005 Feb; 5(2):381-91. PubMed ID: 15652767 [TBL] [Abstract][Full Text] [Related]
4. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury. Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695 [TBL] [Abstract][Full Text] [Related]
5. LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart. Gralinski MR; Park JL; Ozeck MA; Wiater BC; Lucchesi BR J Pharmacol Exp Ther; 1997 Aug; 282(2):554-60. PubMed ID: 9262315 [TBL] [Abstract][Full Text] [Related]
6. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. Pemberton M; Anderson G; VÄ•tvicka V; Justus DE; Ross GD J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606 [TBL] [Abstract][Full Text] [Related]
7. The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. Kilgore KS; Naylor KB; Tanhehco EJ; Park JL; Booth EA; Washington RA; Lucchesi BR J Pharmacol Exp Ther; 1998 Jun; 285(3):987-94. PubMed ID: 9618399 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. Gralinski MR; Wiater BC; Assenmacher AN; Lucchesi BR Immunopharmacology; 1996 Sep; 34(2-3):79-88. PubMed ID: 8886851 [TBL] [Abstract][Full Text] [Related]
9. Effects of complement activation in the isolated heart. Role of the terminal complement components. Homeister JW; Satoh P; Lucchesi BR Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389 [TBL] [Abstract][Full Text] [Related]
10. Effect of treppe on isovolumic function in the isolated blood-perfused mouse heart. Brooks WW; Apstein CS J Mol Cell Cardiol; 1996 Aug; 28(8):1817-22. PubMed ID: 8877791 [TBL] [Abstract][Full Text] [Related]
11. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509 [TBL] [Abstract][Full Text] [Related]
12. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig. Regal JF; Fraser DG; Toth CA J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173 [TBL] [Abstract][Full Text] [Related]
13. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. Cybulsky AV; Quigg RJ; Salant DJ J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914 [TBL] [Abstract][Full Text] [Related]
14. Effect of acute increase of interstitial myocardial fluid on ventricular function in isolated working rat hearts. Barsotti A; Di Napoli P; Dini FL; Soccio M; Di Iorio P; Gallina S; Di Muzio M; Modesti A J Med; 1998; 29(3-4):137-58. PubMed ID: 9865455 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523 [TBL] [Abstract][Full Text] [Related]